References
- CorboCMolinaroRParodiAToledano FurmanNESalvatoreFTasciottiEThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryNanomedicine20161118110026653875
- VromanLAdamsAFischerGCMunozPCInteraction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfacesBlood19805511561597350935
- MahmoudiMSheibaniSMilaniASCrucial role of the protein corona for the specific targeting of nanoparticlesNanomedicine201510221522625600967
- LundqvistMStiglerJEliaGLynchICedervallTDawsonKANanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProc Natl Acad Sci U S A200810538142651427018809927
- SacchettiCMotamedchabokiKMagriniASurface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performanceACS Nano2013731974198923413928
- LynchIDawsonKAProtein-nanoparticle interactionsNano Today2008314047
- KoeglerPClaytonAThissenHSantosGNKingshottPThe influence of nanostructured materials on biointerfacial interactionsAdv Drug Deliv Rev201264151820183922705547
- HühnDKantnerKGeidelCPolymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net chargeACS Nano2013743253326323566380
- FleischerCCPayneCKNanoparticle–cell interactions: molecular structure of the protein corona and cellular outcomesAcc Chem Res20144782651265925014679
- FleischerCCKumarUPayneCKCellular binding of anionic nanoparticles is inhibited by serum proteins independent of nanoparticle compositionBiomater Sci20131997598223956836
- Goy-LópezSJuárezJAlatorre-MedaMPhysicochemical characteristics of protein–NP bioconjugates: the role of particle curvature and solution conditions on human serum albumin conformation and fibrillogenesis inhibitionLangmuir201228249113912622439664
- Orts-GilGNatteKThiermannROn the role of surface composition and curvature on biointerface formation and colloidal stability of nanoparticles in a protein-rich model systemColloids Surf B Biointerfaces201310811011923528607
- StaufenbielSMerinoMLiWSurface characterization and protein interaction of a series of model poly[acrylonitrile-co-(N-vinyl pyrrolidone)] nanocarriers for drug targetingInt J Pharm20154851–2879625746947
- GaucherGAsahinaKWangJLerouxJCEffect of poly (N-vinyl-pyrrolidone)-block-poly (D, L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticlesBiomacromolecules200910240841619133718
- RitzSSchöttlerSKotmanNProtein corona of nanoparticles: distinct proteins regulate the cellular uptakeBiomacromolecules20151641311132125794196
- KangBOkwiekaPSchöttlerSTailoring the stealth properties of biocompatible polysaccharide nanocontainersBiomaterials20154912513425725561
- LundqvistMStiglerJCedervallTThe evolution of the protein corona around nanoparticles: a test studyACS Nano2011597503750921861491
- MaioranoGSabellaSSorceBEffects of cell culture media on the dynamic formation of protein–nanoparticle complexes and influence on the cellular responseACS Nano20104127481749121082814
- MartelJYoungDYoungAComprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography–tandem mass spectrometryAnal Biochem2011418111112521741946
- DobrovolskaiaMAPatriAKZhengJInteraction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profilesNanomedicine20095210611719071065
- JosephDSacharSKishoreNChandraSMechanistic insights into the interactions of magnetic nanoparticles with bovine serum albumin in presence of surfactantsColloids Surf B Biointerfaces201513559660326322473
- PalchettiSColapicchioniVDigiacomoLThe protein corona of circulating PEGylated liposomesBiochim Biophys Acta201618582189196
- TenzerSDocterDKuharevJRapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNat Nanotechnol201381077278124056901
- Sanchez-MorenoPBuzonPBoulaizHBalancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsulesBiomaterials20156126627826005765
- ShubhraQTTothJGyenisJFeczkoTSurface modification of HSA containing magnetic PLGA nanoparticles by poloxamer to decrease plasma protein adsorptionColloids Surf B Biointerfaces201412252953625092588
- LindmanSLynchIThulinENilssonHDawsonKALinseSSystematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicityNano Lett20077491492017335269
- MonopoliMPWalczykDCampbellAPhysical − chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticlesJ Am Chem Soc201113382525253421288025
- DiederichsJEPlasma protein adsorption patterns on liposomes: establishment of analytical procedureElectrophoresis19961736076118740186
- ThodeKLückMSemmlerWMüllerRHKresseMDetermination of plasma protein adsorption on magnetic iron oxides: sample preparationPharm Res19971479059109244148
- CedervallTLynchILindmanSUnderstanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProc Natl Acad Sci U S A200710472050205517267609
- WalkeyCDOlsenJBSongFProtein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticlesACS Nano2014832439245524517450
- WinzenSSchoettlerSBaierGComplementary analysis of the hard and soft protein corona: sample preparation critically effects corona compositionNanoscale2015772992300125599336
- LesniakAFenaroliFMonopoliMPÅbergCDawsonKASalvatiAEffects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cellsACS Nano2012675845585722721453
- GrafeCWeidnerALuheMVIntentional formation of a protein corona on nanoparticles: serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interactionInt J Biochem Cell Biol20167519620226556312
- WangFYuLMonopoliMPThe biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomesNanomedicine2013981159116823660460
- YallapuMMChauhanNOthmanSFImplications of protein corona on physico-chemical and biological properties of magnetic nanoparticlesBiomaterials20154611225678111
- ThieleLDiederichsJEReszkaRMerkleHPWalterECompetitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cellsBiomaterials20032481409141812527282
- BehzadiSSerpooshanVSakhtianchiRProtein corona change the drug release profile of nanocarriers: the “overlooked” factor at the nanobio interfaceColloids Surf B Biointerfaces201412314314925262409
- KangTParkCChoiJSCuiJHLeeBJEffects of shear stress on the cellular distribution of polystyrene nanoparticles in a biomimetic microfluidic systemJ Drug Deliv Sci Technol201631130136
- MariebENHoehnKThe Cardiovascular System: Blood Vessels9th edUpper Saddle River, NJPearson Education, Inc2013
- BhogaleAPatelNMariamJDongrePMiotelloAKothariDComprehensive studies on the interaction of copper nanoparticles with bovine serum albumin using various spectroscopiesColloids Surf B Biointerfaces201411327628424121071
- MahmoudiMAbdelmonemAMBehzadiSTemperature: the “ignored” factor at the NanoBio interfaceACS Nano2013786555656223808533
- O’BrienJSheaKJTuning the protein corona of hydrogel nanoparticles: the synthesis of abiotic protein and peptide affinity reagentsAcc Chem Res20164961200121027254382
- CapriottiALCaraccioloGCarusoGDifferential analysis of “protein corona” profile adsorbed onto different nonviral gene delivery systemsAnal Biochem2011419218018921867671
- MahmoudiMLynchIEjtehadiMRMonopoliMPBombelliFBLaurentSProtein-nanoparticle interactions: opportunities and challengesChem Rev201111195610563721688848
- M’BarekKBMolinoDQuignardSPhagocytosis of immunoglobulin-coated emulsion dropletsBiomaterials20155127027725771017
- ShawSYWestlyECPittetMJSubramanianASchreiberSLWeisslederRPerturbational profiling of nanomaterial biologic activityProc Natl Acad Sci U S A2008105217387739218492802
- SoenenSJHimmelreichUNuyttenNDe CuyperMCytotoxic effects of iron oxide nanoparticles and implications for safety in cell labellingBiomaterials201132119520520863560
- ZhangHJiZXiaTUse of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammationACS Nano2012654349436822502734
- SoenenSJRivera-GilPMontenegroJMParakWJDe SmedtSCBraeckmansKCellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluationNano Today201165446465
- LiuRRalloRGeorgeSClassification NanoSAR development for cytotoxicity of metal oxide nanoparticlesSmall2011781118112621456088
- PuzynTLeszczynskaDLeszczynskiJToward the development of “nano-QSARs”: Advances and challengesSmall20095222494250919787675
- PuzynTRasulevBGajewiczAUsing nano-QSAR to predict the cytotoxicity of metal oxide nanoparticlesNature Nanotechnol20116317517821317892
- FourchesDPuDTassaCQuantitative nanostructure − activity relationship modelingACS Nano20104105703571220857979
- LiuRJiangWWalkeyCDChanWCCohenYPrediction of nanoparticles-cell association based on corona proteins and physicochemical propertiesNanoscale20157219664967525959034
- BigdeliAPalchettiSPozziDExploring cellular interactions of liposomes using protein corona fingerprints and physicochemical propertiesACS Nano20161033723373726882007
- PalchettiSDigiacomoLPozziDNanoparticles-cell association predicted by protein corona fingerprintsNanoscale2016825127551276327279572
- OgawaraKFurumotoKNagayamaSPre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticlesJ Control Release2004100345145515567509
- PengQZhangSYangQPreformed albumin corona, a protective coating for nanoparticles based drug delivery systemBiomaterials201334338521853023932500
- GöppertTMüllerRAdsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targetingInt J Pharm2005302117218616098695
- RodriguezPLHaradaTChristianDAPantanoDATsaiRKDischerDEMinimal “Self” peptides that inhibit phagocytic clearance and enhance delivery of nanoparticlesScience2013339612297197523430657
- GrunérMKauscherULinderMMonopoliMAn environmental route of exposure affects the formation of nanoparticle coronas in blood plasmaJ Proteomics2016137525826546559
- MüllerJBauerKNProzellerDCoating nanoparticles with tunable surfactants facilitates control over the protein coronaBiomaterials20171151827871002
- AggarwalPHallJBMcLelandCBDobrovolskaiaMAMcNeilSENanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdv Drug Deliv Rev200961642843719376175
- WangQSunYZhangZDuanYTargeted polymeric therapeutic nanoparticles: Design and interactions with hepatocellular carcinomaBiomaterials20155622924025934295
- OwensDEPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
- LemarchandCGrefRLesieurSPhysico-chemical characterization of polysaccharide-coated nanoparticlesJ Control Release200510819711116169626
- SzleiferICarignanoMTethered polymer layers: phase transitions and reduction of protein adsorptionMacromol Rapid Commun2000218423448
- NatteKFriedrichJFWohlrabSImpact of polymer shell on the formation and time evolution of nanoparticle – protein coronaColloids Surf B Biointerfaces201310421322023318220
- GrefRDombAQuellecPThe controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresAdv Drug Deliv Rev201264316326
- KnopKHoogenboomRFischerDSchubertUSPoly (ethylene glycol) in drug delivery: pros and cons as well as potential alternativesAngew Chem Int Ed Engl201049366288630820648499
- SchöttlerSBeckerGWinzenSProtein adsorption is required for stealth effect of poly (ethylene glycol)-and poly (phosphoester)-coated nanocarriersNat Nanotechnol201611437237726878141
- RojasLACondezoGNMorenoRAlbumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic deliveryJ Control Release2016237788827388756
- YermolenkoISFuhrmannAMagonovSNOrigin of the nonadhesive properties of fibrinogen matrices probed by force spectroscopyLangmuir20102622172691727720883009
- YermolenkoISGorkunOVFuhrmannAThe assembly of nonadhesive fibrinogen matrices depends on the αC regions of the fibrinogen moleculeJ Biol Chem201228750419794199023086938
- SafiullinRChristensonWOwaynatHFibrinogen matrix deposited on the surface of biomaterials acts as a natural anti-adhesive coatingBiomaterials20156715115926210181
- LishkoVKBurkeTUgarovaTAntiadhesive effect of fibrinogen: a safeguard for thrombus stabilityBlood200710941541154916849640
- StormGBelliotSODaemenTLasicDDSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte systemAdv Drug Deliv Rev19951713148
- CaraccioloGCallipoLDe SanctisSCCavaliereCPozziDLaganàASurface adsorption of protein corona controls the cell internalization mechanism of DC-Chol–DOPE/DNA lipoplexes in serumBiochim Biophys Acta20101798353654319917267
- GaumetMVargasAGurnyRDelieFNanoparticles for drug delivery: the need for precision in reporting particle size parametersEur J Pharm Biopharm20086911917826969
- DengZJLiangMTothIMonteiroMJMinchinRFMolecular interaction of poly (acrylic acid) gold nanoparticles with human fibrinogenACS Nano20126108962896922998416
- ZhuJSunZLiJJZhaoJWBovine serum albumins (BSA) induced aggregation and separation of gold colloid nanoparticlesJ Nanosci Nanotechnol20121232206221122755039
- KendallMDingPKendallKParticle and nanoparticle interactions with fibrinogen: the importance of aggregation in nanotoxicologyNanotoxicology201151556521417688
- Dominguez-MedinaSBlankenburgJOlsonJLandesCFLinkSAdsorption of a protein monolayer via hydrophobic interactions prevents nanoparticle aggregation under harsh environmental conditionsACS Sustain Chem Eng20131783384223914342
- WellsMAAbidAKennedyIMBarakatAISerum proteins prevent aggregation of Fe2O3 and ZnO nanoparticlesNanotoxicology20126883784622149273
- WeisslederRKellyKSunEYShtatlandTJosephsonLCell-specific targeting of nanoparticles by multivalent attachment of small moleculesNat Biotechnol200523111418142316244656
- ZensiABegleyDPontikisCAlbumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neuronesJ Control Release20091371788619285109
- KreuterJHekmataraTDreisSVogelTGelperinaSLangerKCovalent attachment of apolipoprotein AI and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brainJ Control Release20071181545817250920
- VenerandoRMiottoGMagroMMagnetic nanoparticles with covalently bound self-assembled protein corona for advanced biomedical applicationsJ Phys Chem C2013117392032020331
- SchäfflerMSousaFWenkABlood protein coating of gold nanoparticles as potential tool for organ targetingBiomaterials201435103455346624461938
- MirshafieeVMahmoudiMLouKChengJKraftMLProtein corona significantly reduces active targeting yieldChem Commun2013492525572559
- SalvatiAPitekASMonopoliMPTransferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surfaceNat Nanotechnol20138213714323334168
- CaraccioloGLiposome–protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicinesNanomedicine201511354355725555353
- RahmanMLaurentSTawilNYahiaLMahmoudiMProtein-Nanoparticle Interactions151st edBerlin, GermanySpringer-Verlag2013
- CaraccioloGPozziDCapriottiACancer cell targeting of lipid gene vectors by protein coronaNanotechnology20123354357
- ZhangZWangCZhaYCorona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapyACS Nano2015932405241925587629
- PetriBBootzAKhalanskyAChemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly (butyl cyanoacrylate) nanoparticles: revisiting the role of surfactantsJ Control Release20071171515817150277
- BorchardGAudusKLShiFKreuterJUptake of surfactant-coated poly (methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayersInt J Pharm199411012935
- GulyaevAEGelperinaSESkidanINAntropovASKivmanGYKreuterJSignificant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticlesPharm Res199916101564156910554098
- KreuterJPetrovVKharkevichDAlyautdinRInfluence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticlesJ Control Release19974918187
- MirshafieeVKimRParkSMahmoudiMKraftMLImpact of protein pre-coating on the protein corona composition and nanoparticle cellular uptakeBiomaterials20167529530426513421
- LeeYKChoiEJWebsterTJKimSHKhangDEffect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicityInt J Nanomedicine2015109725565807
- CliftMJBhattacharjeeSBrownDMStoneVThe effects of serum on the toxicity of manufactured nanoparticlesToxicol Lett2010198335836520705123
- TedjaRLimMAmalRMarquisCEffects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell linesACS Nano2012654083409322515565
- GeCDuJZhaoLBinding of blood proteins to carbon nanotubes reduces cytotoxicityProc Nat Acad Sci201110841169681697321969544
- ŽūkienėRSnitkaVZinc oxide nanoparticle and bovine serum albumin interaction and nanoparticles influence on cytotoxicity in vitroColloids Surf B Biointerfaces201513531632326275837
- MiottoGMagroMTerzoMProtein corona as a proteome fingerprint: the example of hidden biomarkers for cow mastitisColloids Surf B Biointerfaces2016140404926735893
- ArvizoRRGiriKMoyanoDIdentifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticlesPloS One201273e3365022442705
- MirshafieeVKimRMahmoudiMKraftMLThe importance of selecting a proper biological milieu for protein corona analysis in vitro: human plasma versus human serumInt J Biochem Cell Biol20167518819526643610
- MaioloDDel PinoPMetrangoloPParakWJBaldelli BombelliFNanomedicine delivery: does protein corona route to the target or off road?Nanomedicine201510213231324726470748
- CaraccioloGCaputoDPozziDColapicchioniVCoppolaRSize and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patientsColloids Surf B Biointerfaces201412367367825456990
- HajipourMJLaurentSAghaieARezaeeFMahmoudiMPersonalized protein coronas: a “key” factor at the nanobiointerfaceBiomat Sci20142912101221
- PengQMuHThe potential of protein–nanomaterial interaction for advanced drug deliveryJ Control Release201622512113226812004
- ZanganehSSpitlerRErfanzadehMAlkilanyAMMahmoudiMProtein corona: opportunities and challengesInt J Biochemist Cell Biol201675143147
- MahonESalvatiABombelliFBLynchIDawsonKADesigning the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”J Control Release2012161216417422516097
- Hamad-SchifferliKExploiting the novel properties of protein coronas: emerging applications in nanomedicineNanomedicine (Lond)201510101663167426008198
- SchuchardMMelmCCrawfordHSpecific depletion of twenty high abundance proteins from human plasmaPaper presented at: NCI Proteomic Technologies Reagents Resource WorkshopDecember 12–13; 2005Chicago, IL
- MuQLiuWXingYProtein binding by functionalized multiwalled carbon nanotubes is governed by the surface chemistry of both parties and the nanotube diameterJ Phys Chem C2008112933003307
- LundqvistMSethsonIJonssonBHProtein adsorption onto silica nanoparticles: conformational changes depend on the particles’ curvature and the protein stabilityLangmuir20042024106391064715544396
- XuFReiserMYuXGummuluruSWetzlerLReinhardBMLipid-mediated targeting with membrane-wrapped nanoparticles in the presence of corona formationACS Nano20161011189120026720275
- WalkeyCDOlsenJBGuoHEmiliAChanWCNanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptakeJ Am Chem Soc201213442139214722191645
- TenzerSDocterDRosfaSNanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysisACS Nano2011597155716721866933
- GagnerJELopezMDDordickJSSiegelRWEffect of gold nanoparticle morphology on adsorbed protein structure and functionBiomaterials201132297241725221705074
- ChellatFMerhiYMoreauAYahiaLTherapeutic potential of nanoparticulate systems for macrophage targetingBiomaterials200526357260727516023200
- GessnerAWaiczRLieskeAPaulkeBRMäderKMüllerRNanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorptionInt J Pharm2000196224524910699728